Oxiquim Performance dei guadagni passati

Il passato criteri di controllo 4/6

Oxiquim ha registrato una crescita degli utili a un tasso medio annuo di 12.9%, mentre il settore Chemicals ha registrato utili in crescita a un tasso medio annuo di 12.9%. I ricavi sono stati in crescita a un tasso medio annuo di 10.9%. Il ritorno sul capitale proprio di Oxiquim è 22.5% e ha margini netti di 11.5%.

Informazioni chiave

12.9%

Tasso di crescita degli utili

12.9%

Tasso di crescita dell'EPS

Chemicals Crescita del settore	13.1%
Tasso di crescita dei ricavi	10.9%
Rendimento del capitale proprio	22.5%
Margine netto	11.5%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

May 25

Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 07

Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 11

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Feb 18

Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

Jan 27

Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Dec 28

Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 07

Ripartizione dei ricavi e delle spese

Come Oxiquim guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

SNSE:OXIQUIM Ricavi, spese e utili (CLP Millions )
Data	Ricavi	Guadagni	Spese G+A
30 Jun 24	219,232	25,302	43,121
31 Mar 24	216,232	23,655	42,993
31 Dec 23	214,649	23,896	41,921
30 Sep 23	221,904	24,930	42,204
30 Jun 23	243,733	27,088	43,357
31 Mar 23	258,547	27,220	43,386
31 Dec 22	264,695	29,252	42,902
30 Sep 22	262,663	28,624	41,367
30 Jun 22	238,874	25,710	38,470
31 Mar 22	213,134	24,850	35,558
31 Dec 21	191,128	20,727	33,870
30 Sep 21	170,947	18,471	41,233
30 Jun 21	161,252	18,276	37,019
31 Mar 21	155,708	16,972	34,251
31 Dec 20	158,135	17,219	31,036
30 Sep 20	158,113	16,720	17,762
30 Jun 20	155,569	15,368	17,889
31 Mar 20	155,075	15,874	16,592
31 Dec 19	152,021	15,618	16,199
30 Sep 19	154,655	14,770	17,053
30 Jun 19	157,881	16,018	17,294
31 Mar 19	158,870	15,263	17,153
31 Dec 18	156,502	14,302	17,219
30 Sep 18	151,351	13,534	16,953
30 Jun 18	146,847	12,685	16,481
31 Mar 18	145,208	18,055	17,131
31 Dec 17	144,253	18,294	17,078
30 Sep 17	141,722	21,842	16,111
30 Jun 17	138,877	21,562	15,973
31 Mar 17	135,566	16,033	15,271
31 Dec 16	134,438	16,492	14,998
30 Sep 16	136,729	13,242	14,987
30 Jun 16	140,238	13,054	15,005
31 Mar 16	142,591	12,493	15,002
31 Dec 15	144,059	12,013	14,891
30 Sep 15	144,708	10,554	14,940
30 Jun 15	142,750	9,386	14,199
31 Mar 15	140,734	9,598	13,663
31 Dec 14	140,119	8,592	13,245
30 Sep 14	128,174	8,715	10,506
30 Jun 14	129,377	7,667	11,122
31 Mar 14	134,570	6,195	11,700
31 Dec 13	133,314	5,392	11,600

Guadagni di qualità: OXIQUIM ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di OXIQUIM (11.5%) OXIQUIM sono più alti rispetto allo scorso anno (11.1%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di OXIQUIM sono cresciuti del 12.9% all'anno negli ultimi 5 anni.

Accelerare la crescita: OXIQUIM ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: OXIQUIM ha avuto una crescita negativa degli utili ( -6.6% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Chemicals ( -6.6% ).

Oxiquim Performance dei guadagni passati

Il passato criteri di controllo 4/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Second quarter 2024 earnings released: EPS: CL$295 (vs CL$229 in 2Q 2023)

First quarter 2024 earnings released: EPS: CL$234 (vs CL$244 in 1Q 2023)

Full year 2023 earnings released: EPS: CL$960 (vs CL$1,175 in FY 2022)

Third quarter 2023 earnings released: EPS: CL$222 (vs CL$308 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CL$229 (vs CL$235 in 2Q 2022)

First quarter 2023 earnings released: EPS: CL$0.24 (vs CL$326 in 1Q 2022)

Recent updates

Upcoming dividend of CL$362 per share

Second quarter 2024 earnings released: EPS: CL$295 (vs CL$229 in 2Q 2023)

First quarter 2024 earnings released: EPS: CL$234 (vs CL$244 in 1Q 2023)

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Upcoming dividend of CL$282 per share

New minor risk - Financial position

Full year 2023 earnings released: EPS: CL$960 (vs CL$1,175 in FY 2022)

New minor risk - Financial position

Upcoming dividend of CL$60.00 per share at 10% yield

Third quarter 2023 earnings released: EPS: CL$222 (vs CL$308 in 3Q 2022)

Upcoming dividend of CL$402 per share at 13% yield

Second quarter 2023 earnings released: EPS: CL$229 (vs CL$235 in 2Q 2022)

Upcoming dividend of CL$201 per share at 13% yield

New minor risk - Financial position

First quarter 2023 earnings released: EPS: CL$0.24 (vs CL$326 in 1Q 2022)

Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Full year 2022 earnings released: EPS: CL$1,175 (vs CL$834 in FY 2021)

Third quarter 2022 earnings released: EPS: CL$309 (vs CL$192 in 3Q 2021)

No independent directors

Upcoming dividend of CL$282 per share

Second quarter 2022 earnings released

Upcoming dividend of CL$321 per share

First quarter 2022 earnings released: EPS: CL$326 (vs CL$160 in 1Q 2021)

No independent directors

Full year 2021 earnings released: EPS: CL$834 (vs CL$692 in FY 2020)

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of CL$322 per share

Second quarter 2021 earnings released: EPS CL$200 (vs CL$147 in 2Q 2020)

Upcoming dividend of CL$160 per share

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

First quarter 2021 earnings released: EPS CL$160 (vs CL$170 in 1Q 2020)

Upcoming dividend of CL$120 per share

Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Full year 2020 earnings released: EPS CL$692 (vs CL$628 in FY 2019)

Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

New 90-day high: CL$6,025

New 90-day high: CL$5,500

Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

Third quarter 2020 earnings released: EPS CL$184

Upcoming Dividend of CL$200 Per Share

New 90-day high: CL$5,200

First half earnings released

Ripartizione dei ricavi e delle spese

Storia dei guadagni e delle entrate

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Rendimento del capitale proprio

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate